14 results
424B3
FENC
Fennec Pharmaceuticals Inc
15 Dec 22
Prospectus supplement
5:12pm
or amended to reflect such transaction).
We are required to pay certain fees and expenses incurred by us incident to the registration of the common … will pay all expenses incident to the preparation and filing of the registration statement of which this prospectus forms a part, estimated
424B3
FENC
Fennec Pharmaceuticals Inc
22 Jun 06
Prospectus supplement
12:00am
exceed 8%.
We are required to pay certain fees and expenses incurred by us incident to the registration of the shares. We have agreed to indemnify … of this prospectus to each purchaser at or prior to the time of the sale.
EXPENSES
We are required to pay all fees and expenses incident to the registration
F-3
FENC
Fennec Pharmaceuticals Inc
5 Jun 06
Shelf registration (foreign)
12:00am
receive fees, commissions and markups which, in the aggregate, would exceed 8%.
We are required to pay certain fees and expenses incurred by us incident … are required to pay all fees and expenses incident to the registration of the common shares, including the registration fees. Selling shareholders will pay
424B7
o2g q660g
15 Mar 24
Prospectus with selling stockholder info
3:53pm
8-K
EX-1.1
nvagwe9203ubsf2s
30 Oct 20
Entry into a Material Definitive Agreement
4:40pm
424B3
wnmtrq
20 Apr 18
Prospectus supplement
12:00am
8-K
EX-10.1
489 5dj2ziujvwxzt58
1 Aug 22
Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor
4:15pm
6-K
EX-99.3
rua3g2m7nml
9 May 06
Adherex Announces US$6.5 Million Private Placement
12:00am
8-K
EX-1.1
zaa7u mg7muf
4 May 20
Fennec Announces Proposed Public Offering of Common Shares
12:00am
- Prev
- 1
- Next